These treatments work at the cellular level to fight fatigue, sharpen focus, improve recovery, and support long-term wellness
The reclassification to Category 2 may serve as a catalyst for pharmaceutical companies and research institutions to invest in the rigorous clinical trials required for formal FDA approval
Disclosure of interest: All authors: Nothing to disclose E-Posters - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.01 - DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY P2354 - ESOC25-772 UTILITY OF PRO-ADRENOMEDULLIN DETERMINATION IN THE STROKE CODE: PRESTO STUDY Cristina Sanabria Gago 1 , Raquel Berbegal Serralta 1 , Jaime Alonso 1 , Vanesa Escribano 2 , Beln Colino Galian 2 , Elena Salgado Barbado 2 , Mnica Sobrado Sanz 3 , Carmen Ramos 1 , Alvaro Ximnez-Carrillo 1 , Elisa de la Fuente Sanz 1 , Alicia Gonzalez-Martinez 1 , Carmen Snchez-Rodrguez 1 , Alba Somovilla 1 , Jose Vivancos 1 , Santiago Trillo Senin 1 1 Neurology Department
however these compounds are labelled as research compounds and not for human use, and aren't vetted by the FDA
Most patients describe a brief, mild sting similar to any standard injection
Injections provide a direct, efficient way to replenish B12 stores without relying on oral supplements, which may be less effective for some people
